指南与共识血管炎其他结缔组织病

皮肤血管炎命名:2012年CHCC血管炎命名的皮肤科附录

Nomenclature of Cutaneous Vasculitis: Dermatologic Addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.
指南 / 共识 · Arthritis Rheumatol · 2018-01-01

该皮肤科附录(D-CHCC)基于2012年修订的国际Chapel Hill共识会议血管炎命名(CHCC2012),采用名义群体技术经面对面会议、邮件讨论和电话会议达成共识,为皮肤血管炎制定标准化名称和定义。共识覆盖系统性血管炎的皮肤成分、系统性血管炎的皮肤局限型以及无系统对应者的皮肤单器官血管炎,并引入CHCC2012未包含的皮肤血管炎类型。标准化命名为开发经过验证的皮肤血管炎分类和诊断标准提供前提框架。

要点

  • D-CHCC为皮肤血管炎建立标准化名称和定义,涵盖系统性血管炎皮肤成分、皮肤局限型和皮肤单器官血管炎。
  • 共识采用名义群体技术,经多轮面对面会议、邮件和电话会议达成。
  • 标准化命名是开发皮肤血管炎分类和诊断标准的前提。

核心结论

  • D-CHCC为影响皮肤的血管炎提供标准化名称和定义框架,供临床医生和研究者使用。
  • 标准化名称和定义是开发经过验证的皮肤血管炎分类和诊断标准的前提。

研究设计与样本

  • 采用带促进者的名义群体技术,通过多次面对面会议、电子邮件讨论和电话会议达成D-CHCC命名共识。

主要发现

  • 对系统性血管炎的皮肤成分(如皮肤IgA血管炎作为系统性IgA血管炎的成分)采用标准化名称、定义和描述。
  • 对系统性血管炎的皮肤局限型(如皮肤局限型IgA血管炎、药物诱导的皮肤局限型ANCA相关性血管炎)采用标准化名称、定义和描述。
  • 对无系统对应者的皮肤单器官血管炎(如结节性血管炎)采用标准化名称、定义和描述。
  • 引入了CHCC2012命名中未包含的皮肤血管炎类型。

关键数值与推荐

  • 准确识别特定定义的系统性和皮肤局限型血管炎变型,需要整合临床、实验室和病理学数据的知识。

临床怎么用

  • 临床医生可采用D-CHCC标准化名称和定义描述皮肤血管炎,以统一术语。
  • 研究者可基于D-CHCC框架开发经过验证的皮肤血管炎分类和诊断标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To prepare a dermatologic addendum to the 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides (CHCC2012) to address vasculitides affecting the skin (D-CHCC). The goal was to standardize the names and definitions for cutaneous vasculitis. METHODS: A nominal group technique with a facilitator was used to reach consensus on the D-CHCC nomenclature, using multiple face-to-face meetings, e-mail discussions, and teleconferences. RESULTS: Standardized names, definitions, and descriptions were adopted for cutaneous components of systemic vasculitides (e.g., cutaneous IgA vasculitis as a component of systemic IgA vasculitis), skin-limited variants of systemic vasculitides (e.g., skin-limited IgA vasculitis, drug-induced skin-limited antineutrophil cytoplasmic antibody-associated vasculitis), and cutaneous single-organ vasculitides that have no systemic counterparts (e.g., nodular vasculitis). Cutaneous vasculitides that were not included in the CHCC2012 nomenclature were introduced. CONCLUSION: Standardized names and definitions are a prerequisite for developing validated classification and diagnostic criteria for cutaneous vasculitis. Accurate identification of specifically defined variants of systemic and skin-limited vasculitides requires knowledgeable integration of data from clinical, laboratory, and pathologic studies. This proposed nomenclature of vasculitides affecting the skin, the D-CHCC, provides a standard framework both for clinicians and for investigators.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Sunderkötter CH, Zelger B, Chen KR, et al. Nomenclature of Cutaneous Vasculitis: Dermatologic Addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheumatol. 2018. PMID: 29136340. doi:10.1002/art.40375

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。